US20030083301A1
University of Texas System
The present invention concerns the use of interleukin-1 receptor antagonists for the treatment of spinal cord injuries (SCI). IL-1ra may be administered to a patient with a spinal cord injury in an effective amount. Such methods also include combination therapies in which IL-1ra is administered in …